Diethylamine Salicylate/Sodium aescinate

水杨酸二乙胺/七叶皂苷钠

Report date: 2025/08/14 11:53:49

Base Information

Drug NameDiethylamine Salicylate/Sodium aescinate
Drug Alias Name复方七叶皂苷钠凝胶
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsProstanoid FP receptor agonistsMelanocortin receptor 2 agonists
TargetsCyclooxygenasesProstanoid FP receptorMelanocortin receptor 2
Therapy Area/IndicationsSoft Tissue InjuriesWounds and InjuriesLow Back Pain +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Diethylamine SalicylateSodium aescinate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsSoft Tissue InjuriesLow Back PainVaricose Veins +[6] 
Inactive IndicationsWounds and Injuries

Other Information

ATC CodeN/A
Related LinksN/A